Gefitinib (‘Iressa’, ZD1839) and new epidermal growth factor receptor inhibitors

Những quyển sách tương tự

• Analysis of epidermal growth factor receptor expression as a predictive factor for response to gefitinib (‘Iressa’, ZD1839) in non-small-cell lung cancer
  Bằng: Parra, H S, et al.
  Được phát hành: (2004)
• Gefitinib (‘Iressa’, ZD1839) inhibits the growth response of bladder tumour cell lines to epidermal growth factor and induces TIMP2
  Bằng: Nutt, J E, et al.
  Được phát hành: (2004)
• Additive antitumour effect of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib (Iressa, ZD1839) and the antioestrogen fulvestrant (Faslodex, ICI 182,780) in breast cancer cells
  Bằng: Okubo, S, et al.
  Được phát hành: (2004)
• The effect of ZD1839 (Iressa(TM)), an epidermal growth factor receptor tyrosine kinase inhibitor, in combination with cisplatin, on apoptosis in SCC‐15 cells
  Bằng: Al‐Hazzaa, A., et al.
  Được phát hành: (2005)
• Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 (‘Iressa’)
  Bằng: Sewell, J M, et al.
  Được phát hành: (2002)